Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammography | 47 | 2023 | 2475 | 6.990 |
Why?
|
| Breast Neoplasms | 64 | 2023 | 20827 | 4.580 |
Why?
|
| Ultrasonography, Mammary | 14 | 2023 | 250 | 3.860 |
Why?
|
| Breast | 18 | 2023 | 1970 | 2.880 |
Why?
|
| Calcinosis | 7 | 2023 | 1495 | 1.630 |
Why?
|
| Burnout, Professional | 5 | 2022 | 694 | 1.430 |
Why?
|
| Early Detection of Cancer | 16 | 2023 | 3089 | 1.340 |
Why?
|
| Breast Diseases | 5 | 2016 | 443 | 1.310 |
Why?
|
| Radiographic Image Enhancement | 10 | 2023 | 885 | 1.250 |
Why?
|
| Magnetic Resonance Imaging | 20 | 2023 | 35409 | 1.170 |
Why?
|
| Continuity of Patient Care | 3 | 2019 | 1049 | 1.120 |
Why?
|
| Image Enhancement | 5 | 2016 | 2915 | 1.060 |
Why?
|
| Radiology | 6 | 2022 | 2099 | 0.790 |
Why?
|
| Retrospective Studies | 51 | 2023 | 77410 | 0.770 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2017 | 1184 | 0.670 |
Why?
|
| Biopsy, Needle | 5 | 2022 | 1639 | 0.660 |
Why?
|
| Mass Screening | 11 | 2022 | 5251 | 0.650 |
Why?
|
| Mammary Glands, Human | 1 | 2019 | 199 | 0.610 |
Why?
|
| Academic Medical Centers | 6 | 2023 | 2760 | 0.540 |
Why?
|
| Female | 67 | 2023 | 380020 | 0.540 |
Why?
|
| Diagnostic Errors | 2 | 2014 | 1256 | 0.530 |
Why?
|
| Precancerous Conditions | 2 | 2019 | 975 | 0.520 |
Why?
|
| Thoracic Diseases | 2 | 2016 | 97 | 0.510 |
Why?
|
| Sensitivity and Specificity | 12 | 2023 | 14714 | 0.490 |
Why?
|
| Carcinoma, Lobular | 4 | 2021 | 484 | 0.480 |
Why?
|
| Hospital Information Systems | 1 | 2016 | 395 | 0.480 |
Why?
|
| Soft Tissue Infections | 1 | 2016 | 155 | 0.470 |
Why?
|
| Lymphatic Diseases | 1 | 2016 | 323 | 0.470 |
Why?
|
| Humans | 92 | 2023 | 743811 | 0.470 |
Why?
|
| Quality Improvement | 3 | 2021 | 3750 | 0.470 |
Why?
|
| Axilla | 3 | 2023 | 597 | 0.460 |
Why?
|
| Resilience, Psychological | 1 | 2020 | 677 | 0.450 |
Why?
|
| Aftercare | 1 | 2019 | 870 | 0.440 |
Why?
|
| Biopsy | 9 | 2022 | 6750 | 0.430 |
Why?
|
| Carcinoma | 3 | 2019 | 2375 | 0.410 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 1486 | 0.390 |
Why?
|
| Diagnosis, Differential | 13 | 2020 | 12954 | 0.390 |
Why?
|
| Contrast Media | 5 | 2019 | 5301 | 0.370 |
Why?
|
| Abscess | 1 | 2014 | 607 | 0.370 |
Why?
|
| Ultrasonography, Doppler | 2 | 2002 | 458 | 0.350 |
Why?
|
| Neoadjuvant Therapy | 1 | 2020 | 2727 | 0.340 |
Why?
|
| Middle Aged | 36 | 2023 | 213241 | 0.330 |
Why?
|
| Adult | 36 | 2021 | 213889 | 0.320 |
Why?
|
| Aged | 32 | 2021 | 163178 | 0.320 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2023 | 710 | 0.300 |
Why?
|
| Vascular Diseases | 1 | 2016 | 1161 | 0.300 |
Why?
|
| Neoplasms | 4 | 2023 | 21675 | 0.290 |
Why?
|
| Job Satisfaction | 2 | 2020 | 535 | 0.280 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2021 | 9239 | 0.280 |
Why?
|
| Artifacts | 3 | 2023 | 1904 | 0.280 |
Why?
|
| Inflammatory Breast Neoplasms | 2 | 2021 | 143 | 0.280 |
Why?
|
| Mastectomy, Segmental | 3 | 2000 | 956 | 0.270 |
Why?
|
| Aged, 80 and over | 16 | 2020 | 57744 | 0.270 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 2291 | 0.260 |
Why?
|
| Self Report | 3 | 2021 | 3550 | 0.260 |
Why?
|
| Reproducibility of Results | 7 | 2020 | 19894 | 0.250 |
Why?
|
| Gadolinium DTPA | 2 | 2019 | 836 | 0.250 |
Why?
|
| Observer Variation | 4 | 2018 | 2592 | 0.220 |
Why?
|
| Electronics | 2 | 2021 | 321 | 0.220 |
Why?
|
| Carcinoma, Ductal, Breast | 3 | 2018 | 1100 | 0.220 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 3608 | 0.200 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2017 | 948 | 0.190 |
Why?
|
| Lymph Nodes | 2 | 2023 | 3476 | 0.190 |
Why?
|
| Thrombophlebitis | 1 | 2001 | 309 | 0.180 |
Why?
|
| Faculty | 2 | 2021 | 386 | 0.180 |
Why?
|
| Predictive Value of Tests | 5 | 2023 | 15067 | 0.180 |
Why?
|
| Referral and Consultation | 3 | 2023 | 3530 | 0.180 |
Why?
|
| Arm | 1 | 2002 | 588 | 0.170 |
Why?
|
| Subcutaneous Fat | 1 | 2023 | 391 | 0.170 |
Why?
|
| Physicians | 3 | 2022 | 4569 | 0.170 |
Why?
|
| Neoplasms, Second Primary | 3 | 2018 | 1063 | 0.160 |
Why?
|
| Computer Systems | 1 | 2000 | 481 | 0.160 |
Why?
|
| Catheterization, Central Venous | 1 | 2002 | 514 | 0.150 |
Why?
|
| Internship and Residency | 1 | 2018 | 5787 | 0.150 |
Why?
|
| Mastectomy | 2 | 2023 | 1793 | 0.150 |
Why?
|
| Reimbursement, Incentive | 1 | 2022 | 540 | 0.140 |
Why?
|
| Abdominal Neoplasms | 1 | 1998 | 292 | 0.140 |
Why?
|
| Nipples | 1 | 1998 | 219 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 4 | 2018 | 3617 | 0.140 |
Why?
|
| Lymphatic Metastasis | 2 | 2023 | 2924 | 0.140 |
Why?
|
| Pelvic Neoplasms | 1 | 1998 | 254 | 0.140 |
Why?
|
| Workload | 2 | 2020 | 849 | 0.140 |
Why?
|
| False Negative Reactions | 1 | 2017 | 588 | 0.130 |
Why?
|
| Fibroma | 1 | 2017 | 212 | 0.130 |
Why?
|
| Vulnerable Populations | 1 | 2021 | 685 | 0.130 |
Why?
|
| Body Piercing | 1 | 2014 | 7 | 0.130 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2019 | 717 | 0.120 |
Why?
|
| Cattle | 1 | 2020 | 3917 | 0.120 |
Why?
|
| Algorithms | 3 | 2023 | 13869 | 0.120 |
Why?
|
| Models, Animal | 1 | 2020 | 2172 | 0.120 |
Why?
|
| Breast Implants | 1 | 2017 | 387 | 0.110 |
Why?
|
| Venous Thrombosis | 1 | 2002 | 1240 | 0.110 |
Why?
|
| Suction | 1 | 2014 | 267 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2017 | 8939 | 0.110 |
Why?
|
| User-Computer Interface | 1 | 2000 | 1431 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2016 | 3320 | 0.110 |
Why?
|
| Propensity Score | 1 | 2019 | 1781 | 0.110 |
Why?
|
| Pressure | 1 | 2016 | 1205 | 0.110 |
Why?
|
| Young Adult | 6 | 2017 | 56392 | 0.110 |
Why?
|
| Preoperative Care | 1 | 2021 | 2251 | 0.100 |
Why?
|
| Ultrasonography | 5 | 2020 | 5986 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2011 | 5691 | 0.100 |
Why?
|
| Follow-Up Studies | 7 | 2023 | 39001 | 0.100 |
Why?
|
| Testicular Diseases | 2 | 2003 | 71 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2022 | 5078 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2023 | 3280 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2016 | 2369 | 0.090 |
Why?
|
| Premenopause | 1 | 2013 | 1033 | 0.080 |
Why?
|
| Risk Factors | 6 | 2017 | 72252 | 0.080 |
Why?
|
| Drainage | 1 | 2014 | 1142 | 0.080 |
Why?
|
| Surgical Procedures, Operative | 1 | 2000 | 1877 | 0.080 |
Why?
|
| Postpartum Period | 1 | 2014 | 1086 | 0.080 |
Why?
|
| Internet | 1 | 2000 | 3058 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 11036 | 0.070 |
Why?
|
| Breast Feeding | 1 | 2014 | 1338 | 0.070 |
Why?
|
| Testicular Neoplasms | 2 | 2003 | 803 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2021 | 4467 | 0.060 |
Why?
|
| Weight Loss | 1 | 2016 | 2625 | 0.060 |
Why?
|
| Pandemics | 2 | 2021 | 8385 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4251 | 0.060 |
Why?
|
| Boston | 1 | 2017 | 9310 | 0.060 |
Why?
|
| Adolescent | 5 | 2017 | 85729 | 0.060 |
Why?
|
| Patient Selection | 1 | 2016 | 4210 | 0.060 |
Why?
|
| Massachusetts | 1 | 2016 | 8660 | 0.060 |
Why?
|
| Comorbidity | 2 | 2017 | 10380 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 3921 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2014 | 2683 | 0.060 |
Why?
|
| Medicare | 1 | 2021 | 6565 | 0.060 |
Why?
|
| Registries | 1 | 2018 | 8090 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 13980 | 0.060 |
Why?
|
| Calculi | 1 | 2003 | 46 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 3503 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2018 | 4687 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3134 | 0.050 |
Why?
|
| Decision Making | 1 | 2016 | 3887 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2013 | 2528 | 0.050 |
Why?
|
| United States | 2 | 2021 | 69859 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2017 | 4599 | 0.050 |
Why?
|
| Lithiasis | 1 | 2001 | 20 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2018 | 20121 | 0.050 |
Why?
|
| Germinoma | 1 | 2001 | 134 | 0.050 |
Why?
|
| Prevalence | 1 | 2016 | 15211 | 0.040 |
Why?
|
| Teleradiology | 1 | 1999 | 53 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 1998 | 6773 | 0.040 |
Why?
|
| Vena Cava Filters | 1 | 2001 | 253 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2000 | 15281 | 0.040 |
Why?
|
| Workflow | 1 | 2022 | 847 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2021 | 1185 | 0.040 |
Why?
|
| Appointments and Schedules | 1 | 2021 | 417 | 0.040 |
Why?
|
| Smoking | 1 | 2014 | 8984 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15526 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 3503 | 0.030 |
Why?
|
| Cancer Care Facilities | 1 | 2018 | 402 | 0.030 |
Why?
|
| Keratins | 1 | 2017 | 515 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 5752 | 0.030 |
Why?
|
| Polyps | 1 | 1997 | 189 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2020 | 689 | 0.030 |
Why?
|
| Incidence | 1 | 2012 | 20948 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2000 | 915 | 0.030 |
Why?
|
| Endometrium | 1 | 1997 | 423 | 0.030 |
Why?
|
| Internal Medicine | 1 | 2021 | 1009 | 0.030 |
Why?
|
| Kinetics | 1 | 2021 | 6476 | 0.030 |
Why?
|
| Pregnancy | 2 | 2014 | 29140 | 0.030 |
Why?
|
| Video Recording | 1 | 2018 | 949 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2018 | 2971 | 0.030 |
Why?
|
| Stereotaxic Techniques | 1 | 1995 | 535 | 0.030 |
Why?
|
| Tamoxifen | 1 | 1997 | 981 | 0.030 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1994 | 255 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2018 | 40545 | 0.020 |
Why?
|
| Radiography | 1 | 2022 | 7010 | 0.020 |
Why?
|
| Fatty Liver | 1 | 1997 | 728 | 0.020 |
Why?
|
| Spleen | 1 | 1997 | 2359 | 0.020 |
Why?
|
| Radiology Information Systems | 1 | 1996 | 523 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2022 | 3391 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 1996 | 981 | 0.020 |
Why?
|
| Carcinoma in Situ | 1 | 1995 | 805 | 0.020 |
Why?
|
| Software | 2 | 2000 | 4440 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 1997 | 1523 | 0.020 |
Why?
|
| Animals | 1 | 2020 | 168660 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 2001 | 2375 | 0.020 |
Why?
|
| Male | 6 | 2016 | 349776 | 0.020 |
Why?
|
| HIV Infections | 1 | 2014 | 16715 | 0.020 |
Why?
|
| Prognosis | 2 | 2018 | 29052 | 0.020 |
Why?
|
| Logistic Models | 1 | 2002 | 13404 | 0.020 |
Why?
|
| Endometrial Neoplasms | 1 | 1997 | 1350 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2018 | 23327 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1994 | 1381 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2022 | 53250 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2018 | 9848 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 11360 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1997 | 4925 | 0.010 |
Why?
|
| Liver | 1 | 1997 | 7479 | 0.010 |
Why?
|
| Time Factors | 2 | 2000 | 40038 | 0.010 |
Why?
|
| Orchiectomy | 1 | 2001 | 468 | 0.010 |
Why?
|
| Testis | 1 | 2001 | 795 | 0.010 |
Why?
|
| Therapy, Computer-Assisted | 1 | 1999 | 271 | 0.010 |
Why?
|
| X-Ray Intensifying Screens | 1 | 1996 | 32 | 0.010 |
Why?
|
| Computer Terminals | 1 | 1996 | 44 | 0.010 |
Why?
|
| Probability | 1 | 2001 | 2505 | 0.010 |
Why?
|
| Breast Neoplasms, Male | 1 | 1997 | 210 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1997 | 1422 | 0.010 |
Why?
|
| Reference Standards | 1 | 1997 | 1023 | 0.010 |
Why?
|
| Radiography, Abdominal | 1 | 1996 | 537 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1997 | 1770 | 0.010 |
Why?
|
| Lymphoma, Follicular | 1 | 1994 | 435 | 0.010 |
Why?
|
| Research | 1 | 1999 | 1999 | 0.010 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 1996 | 778 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 1995 | 1095 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1996 | 25609 | 0.000 |
Why?
|
| Child | 1 | 1996 | 77637 | 0.000 |
Why?
|
Concepts
(211)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(59)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_